Annual EBITDA
$70.63M$6.17M+9.56%
Summary
- Current Value
- As of today, PGNY annual EBITDA is $70.63M, up +9.56% on
- Historical Performance
- PGNY annual EBITDA is up +109.95% over the past 3 years, and up +498.05% over the past 5 years
- All-Time High Comparison
- PGNY annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- PGNY annual EBITDA is +183.18% above its 3-year low of $24.94M reached on an earlier date
- Sector Comparison
- PGNY annual EBITDA is higher than 85.34% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $70.63M | +9.6% | +110.0% | +498.1% | +847.7% | |
| Quarterly EBITDA | $22.80M | +71.5% | +95.5% | +330.9% | +1731.7% | |
| TTM EBITDA | $90.29M | +32.0% | +323.5% | +775.5% | +6563.2% | |
| Price | $26.63 | +52.4% | -5.4% | -41.2% | – | |
| PE Ratio | 42.16 | +36.3% | -54.5% | -56.5% | – | |
| Annual Revenue | $1.17B | +7.2% | +133.2% | +408.2% | +2302.5% | |
| Annual EPS | $0.57 | -7.6% | -13.1% | +655.4% | +447.6% | |
| Annual EBIT | $67.46M | +8.5% | +108.6% | +597.1% | +713.0% | |
| Annual Net Income | $54.34M | -12.4% | -17.4% | +734.1% | +536.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $70.63M | at high | |
| 5Y | $70.63M | at high | |
| All | $70.63M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $24.94M | N/A | +183.2% |
| 5Y | $10.25M | N/A | +588.8% |
| All | -$9.45M | +847.7% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $70.63M | +9.6% | |
| $64.47M | +158.5% | |
| $24.94M | -25.9% | |
| $33.64M | +228.1% |
| Year | Value | Change |
|---|---|---|
| $10.25M | -13.2% | |
| $11.81M | +852.7% | |
| -$1.57M | +83.4% | |
| -$9.45M | - |
FAQ
What is the current annual EBITDA of PGNY?
As of today, PGNY annual EBITDA is $70.63M
What is 1-year change in PGNY annual EBITDA?
PGNY annual EBITDA is up +9.56% year-over-year
What is 3-year change in PGNY annual EBITDA?
PGNY annual EBITDA is up +109.95% over the past 3 years
How far is PGNY annual EBITDA from its all-time high?
PGNY annual EBITDA is currently at its all-time high
How does PGNY annual EBITDA rank versus sector peers?
PGNY annual EBITDA is higher than 85.34% of companies in Healthcare sector
When is PGNY next annual earnings release?
The next annual earnings release for PGNY is on
Quarterly EBITDA
$22.80M$2.77M-10.83%
Summary
- Current Value
- As of today, PGNY quarterly EBITDA is $22.80M, down -10.83% on
- Historical Performance
- PGNY quarterly EBITDA is up +71.46% year-over-year, and up +95.50% over the past 3 years
- All-Time High Comparison
- PGNY quarterly EBITDA is currently -10.83% below its historical high of $25.56M set on
- 3-Year Low Comparison
- PGNY quarterly EBITDA is +507.54% above its 3-year low of $3.75M reached on an earlier date
- Sector Comparison
- PGNY quarterly EBITDA is higher than 82.13% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $22.80M | -10.8% | +71.5% | +95.5% | +330.9% | |
| Annual EBITDA | $70.63M | – | +9.6% | +110.0% | +498.1% | |
| TTM EBITDA | $90.29M | +11.8% | +32.0% | +323.5% | +775.5% | |
| Price | $26.63 | +33.1% | +52.4% | -5.4% | -41.2% | |
| PE Ratio | 42.16 | +33.1% | +36.3% | -54.5% | -56.5% | |
| Quarterly Revenue | $313.35M | -5.9% | +9.3% | +52.6% | +216.7% | |
| Quarterly EPS | $0.15 | -19.5% | +38.3% | +16.1% | +215.6% | |
| Quarterly EBIT | $21.53M | -11.6% | +72.8% | +91.3% | +345.9% | |
| Quarterly Net Income | $13.86M | -19.0% | +33.0% | +4.9% | +187.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $25.56M | -10.8% | |
| 3Y | $25.56M | -10.8% | |
| 5Y | $25.56M | -10.8% | |
| All | $25.56M | -10.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $16.66M | N/A | +36.9% |
| 3Y | $3.75M | N/A | +507.5% |
| 5Y | $128.00K | >+9999.0% | |
| All | -$1.40M | +1731.7% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of PGNY?
As of today, PGNY quarterly EBITDA is $22.80M
What is PGNY quarterly EBITDA most recent change?
PGNY quarterly EBITDA was down -10.83% on September 30, 2025
What is 1-year change in PGNY quarterly EBITDA?
PGNY quarterly EBITDA is up +71.46% year-over-year
How far is PGNY quarterly EBITDA from its all-time high?
PGNY quarterly EBITDA is currently -10.83% below its historical high of $25.56M set on June 30, 2025
How does PGNY quarterly EBITDA rank versus sector peers?
PGNY quarterly EBITDA is higher than 82.13% of companies in Healthcare sector
When is PGNY next earnings release?
The next earnings release for PGNY is on
TTM EBITDA
$90.29M$9.50M+11.76%
Summary
- Current Value
- As of today, PGNY TTM EBITDA is $90.29M, up +11.76% on
- Historical Performance
- PGNY TTM EBITDA is up +31.99% year-over-year, and up +323.54% over the past 3 years
- All-Time High Comparison
- PGNY TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- PGNY TTM EBITDA is +262.00% above its 3-year low of $24.94M reached on an earlier date
- Sector Comparison
- PGNY TTM EBITDA is higher than 83.39% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $90.29M | +11.8% | +32.0% | +323.5% | +775.5% | |
| Annual EBITDA | $70.63M | – | +9.6% | +110.0% | +498.1% | |
| Quarterly EBITDA | $22.80M | -10.8% | +71.5% | +95.5% | +330.9% | |
| Price | $26.63 | +33.1% | +52.4% | -5.4% | -41.2% | |
| PE Ratio | 42.16 | +33.1% | +36.3% | -54.5% | -56.5% | |
| TTM Revenue | $1.27B | +2.1% | +11.4% | +81.2% | +309.7% | |
| TTM EPS | $0.63 | +7.2% | +8.8% | +50.2% | +3058.0% | |
| TTM EBIT | $85.84M | +11.8% | +31.1% | +332.5% | +930.4% | |
| TTM Net Income | $56.57M | +6.5% | -1.2% | +34.6% | +1793.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $90.29M | at high | |
| 3Y | $90.29M | at high | |
| 5Y | $90.29M | at high | |
| All | $90.29M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $70.63M | N/A | +27.8% |
| 3Y | $24.94M | N/A | +262.0% |
| 5Y | $10.25M | N/A | +780.6% |
| All | -$1.40M | +6563.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of PGNY?
As of today, PGNY TTM EBITDA is $90.29M
What is PGNY TTM EBITDA most recent change?
PGNY TTM EBITDA was up +11.76% on September 30, 2025
What is 1-year change in PGNY TTM EBITDA?
PGNY TTM EBITDA is up +31.99% year-over-year
How far is PGNY TTM EBITDA from its all-time high?
PGNY TTM EBITDA is currently at its all-time high
How does PGNY TTM EBITDA rank versus sector peers?
PGNY TTM EBITDA is higher than 83.39% of companies in Healthcare sector
When is PGNY next earnings release?
The next earnings release for PGNY is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- PGNY Official Website www.progyny.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1551306/000155130625000190/0001551306-25-000190-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1551306/000155130625000040/0001551306-25-000040-index.htm
- PGNY Profile on Yahoo Finance finance.yahoo.com/quote/PGNY
- PGNY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pgny